Hotel Dieu Shaver Health and Rehabilitation Centre is Niagara's only specialty rehabilitation hospital, located in the south-end of St. Catharines, Ontario. Its mandate is to provide complex continuing care and rehabilitation services to patients in the city and Niagara Region.

There are 134 beds in Hotel Dieu Health Sciences Hospital - Niagara.

During the past decade, Hotel Dieu Health Sciences Hospital - Niagara conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hotel Dieu Health Sciences Hospital - Niagara" #1 sponsor was "NCIC Clinical Trials Group" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "AGO Study Group" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hotel Dieu Health Sciences Hospital - Niagara" #1 collaborator was "NCIC Clinical Trials Group" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hotel Dieu Health Sciences Hospital - Niagara" are "Lung Cancer" (4 trials), "Breast Cancer" (3 trials), "Colorectal Cancer" (3 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (3 trials) and "Quality of Life" (3 trials). Many other conditions were trialed in "Hotel Dieu Health Sciences Hospital - Niagara" in a lesser frequency.

Most popular intervention types in "Hotel Dieu Health Sciences Hospital - Niagara" are "Drug" (19 trials), "Biological" (3 trials), "Procedure" (3 trials), "Genetic" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "prednisone" (4 trials), "cisplatin" (3 trials), "gemcitabine hydrochloride" (3 trials), "quality-of-life assessment" (3 trials) and "alvocidib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hotel Dieu Health Sciences Hospital - Niagara" are 16 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hotel Dieu Health Sciences Hospital - Niagara". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Hotel Dieu Health Sciences Hospital - Niagara, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hotel Dieu Health Sciences Hospital - Niagara, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".